XML 78 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 20,294 $ 9,974
General and administrative 6,844 5,702
Total operating expenses 27,138 15,676
Loss from operations (27,138) (15,676)
Other income (expense):    
Interest income 1,561 1,827
Interest expense (545) (598)
Loss on debt extinguishment 0 (681)
Other, net (115) (41)
Total other income, net 901 507
Net loss (26,237) (15,169)
Other comprehensive income (loss):    
Change in fair value attributable to instrument specific credit risk 7 134
Foreign currency translation (16) (19)
Total other comprehensive income (loss) (9) 115
Comprehensive loss $ (26,246) $ (15,054)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.80) $ (0.56)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.80) $ (0.56)
Weighted-average number of common shares outstanding, basic (in shares) 32,893,000 27,049,000
Weighted-average number of common shares outstanding, diluted (in shares) 32,893,000 27,049,000